CD4 and type 2 diabetes mellitus: Some studies reported advanced glycation end products would promote CD4+ T cells differentiation toward pro-inflammatory state 13, whereas regulatory T cells exhibit reversing role on insulin resistance in Type 2 diabetes 14, indicating that the dysregulation of CD4+ T cells was implicated in the inflammatory response during diabetes.